NASDAQ: GRCEGrace Therapeutics Inc Stock Ownership - Who owns Grace Therapeutics?
Insider buying vs selling
Have Grace Therapeutics Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when GRCE insiders and whales buy or sell their stock.
GRCE Shareholders
What type of owners hold Grace Therapeutics Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Grace 2018 Irrevocable Trust Rajitha | 28.82% | 4,689,547 | $9.75M | Insider |
| Adar1 Capital Management LLC | 5.90% | 959,571 | $2.00M | Insider |
| Cerity Partners LLC | 5.22% | 849,055 | $1.77M | Institution |
| Eversept Partners LP | 4.65% | 756,600 | $1.57M | Institution |
| Nantahala Capital Management LLC | 4.47% | 728,203 | $1.51M | Institution |
| Bank Of America Corp | 3.04% | 494,723 | $1.03M | Institution |
| George Kottayil | 3.04% | 494,698 | $1.03M | Insider |
| Vanguard Capital Management LLC | 2.47% | 401,656 | $835.44k | Institution |
| William A. Haseltine | 2.05% | 332,836 | $692.30k | Insider |
| Renaissance Technologies LLC | 1.50% | 243,910 | $507.33k | Institution |
GRCE vs Biotech Stocks
Grace Therapeutics Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.